|
Nevada
(State or Other
Jurisdiction of
Incorporation)
|
1-10245
(Commission File
Number)
|
95-1480559
(I.R.S. Employer
Identification No.)
|
|
2500 McClellan Avenue, Suite 350
|
||
|
Pennsauken, NJ
|
08109-4613
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
|
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240-14d-2(b)).
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c)).
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
|
Common Stock, par value $0.05 per share
|
RCMT
|
The NASDAQ Stock Market LLC
|
| Item 2.02. |
Results of Operations and Financial Condition.
|
|
Exhibit Number
|
|
|
Press Release by the Registrant, dated August 10, 2020, furnished in accordance with Item 2.02 of this Current Report on Form 8-K.
|
|
By:
|
/s/ Kevin D. Miller
|
|
Kevin D. Miller
|
|
|
Chief Financial Officer, Treasurer and
Secretary
|

|
RCM Technologies, Inc.
|
Tel: 856.356.4500
|
Corporate Contacts:
|
|
2500 McClellan Avenue
|
Fax: 856.356.4600
|
Bradley S. Vizi
|
|
Pennsauken, NJ 08109
|
Executive Chairman
|
|
|
www.rcmt.com
|
Kevin D. Miller
|
|
|
Chief Financial Officer
|
|
Thirteen Week Periods Ended
|
||||
|
June 27, 2020
|
June 29, 2019
|
|||
|
Revenue
|
$32,652
|
$50,705
|
||
|
Cost of services
|
24,149
|
37,902
|
||
|
Gross profit
|
8,503
|
12,803
|
||
|
Selling, general and administrative
|
8,994
|
10,202
|
||
|
Depreciation and amortization of property and equipment
|
246
|
325
|
||
|
Amortization of acquired intangible assets
|
80
|
83
|
||
|
Write-off of receivables and professional fees incurred related to arbitration
|
350
|
-
|
||
|
Operating (loss) income
|
(1,167
|
)
|
2,193
|
|
|
Other expense, net
|
233
|
483
|
||
|
(Loss) income before income taxes
|
(1,400
|
)
|
1,710
|
|
|
Income tax (benefit) expense
|
(408
|
)
|
459
|
|
|
Net (loss) income
|
($992
|
)
|
$1,251
|
|
|
Diluted net (loss) earnings per share data
|
($0.08
|
)
|
$0.10
|
|
|
Twenty-Six Week Periods Ended
|
||||
|
June 27, 2020
|
June 29, 2019
|
|||
|
Revenue
|
$77,685
|
$102,300
|
||
|
Cost of services
|
58,339
|
76,980
|
||
|
Gross profit
|
19,346
|
25,320
|
||
|
Selling, general and administrative
|
19,231
|
20,667
|
||
|
Depreciation and amortization of property and equipment
|
501
|
640
|
||
|
Amortization of acquired intangible assets
|
160
|
165
|
||
|
Write-off of receivables and professional fees incurred related to arbitration
|
8,397
|
-
|
||
|
Operating (loss) income
|
(8,943
|
)
|
3,848
|
|
|
Other expense, net
|
642
|
949
|
||
|
(Loss) income before income taxes
|
(9,585
|
)
|
2,899
|
|
|
Income tax (benefit) expense
|
(2,648
|
)
|
185
|
|
|
Net (loss) income
|
($6,937
|
)
|
$2,714
|
|
|
Diluted net (loss) earnings per share data
|
($0.54
|
)
|
$0.21
|
|
|
June 27,
2020
|
December 28,
2019
|
||
|
(Unaudited)
|
|||
|
Cash and cash equivalents
|
$1,632
|
$1,847
|
|
|
Accounts receivable, net
|
$39,519
|
$59,760
|
|
|
Total current assets
|
$43,646
|
$70,657
|
|
|
Total assets
|
$70,178
|
$96,173
|
|
|
Total current liabilities
|
$21,152
|
$21,408
|
|
|
Borrowing under line of credit
|
$17,363
|
$34,761
|
|
|
Net debt (line of credit less cash)
|
$15,731
|
$32,914
|
|
|
Note payable
|
$2,230
|
-
|
|
|
Total liabilities
|
$46,640
|
$63,770
|
|
|
Stockholders’ equity
|
$23,538
|
$32,403
|
|
Thirteen Week
Periods Ended
|
Twenty-Six Week
Periods Ended
|
|||||||
|
June 27,
2020
|
June 29,
2019
|
June 27,
2020
|
June 29,
2019
|
|||||
|
GAAP net (loss) income
|
($992
|
)
|
$1,251
|
($6,937
|
)
|
$2,714
|
||
|
Income tax (benefit) expense
|
(408
|
)
|
459
|
(2,648
|
)
|
185
|
||
|
Interest expense
|
184
|
458
|
524
|
887
|
||||
|
Imputed interest on contingent consideration
|
36
|
48
|
72
|
96
|
||||
|
Depreciation of property and equipment
|
246
|
325
|
501
|
640
|
||||
|
Amortization of acquired intangible assets
|
80
|
83
|
160
|
165
|
||||
|
EBITDA (non-GAAP)
|
($854
|
)
|
$2,624
|
($8,328
|
)
|
$4,687
|
||
|
Adjustments
|
||||||||
|
Write-off of receivables and professional fees
incurred related to arbitration
|
350
|
-
|
8,397
|
-
|
||||
|
Loss (gain) on foreign currency transactions
|
13
|
(23
|
)
|
46
|
(34
|
)
|
||
|
Adjusted EBITDA (non-GAAP)
|
($491
|
)
|
$2,601
|
$115
|
$4,653
|
|||
|
Thirteen Week Periods Ended
|
|||||
|
June 27,
2020
|
June 29,
2019
|
||||
|
Net (loss) income
|
($992
|
)
|
$1,251
|
||
|
Adjustments to reconcile net income to cash
used in operating activities
|
(38
|
)
|
761
|
||
|
Changes in operating assets and liabilities:
|
|||||
|
Accounts receivable
|
11,253
|
353
|
|||
|
Prepaid expenses and other current assets
|
1,620
|
548
|
|||
|
Net of transit accounts receivable and payable
|
(66
|
)
|
917
|
||
|
Accounts payable and accrued expenses
|
2,745
|
(639
|
)
|
||
|
Accrued payroll and related costs
|
2,239
|
(345
|
)
|
||
|
Right of use assets and liabilities
|
(17
|
)
|
(7
|
)
|
|
|
Income taxes payable
|
110
|
239
|
|||
|
Total adjustments
|
17,846
|
1,827
|
|||
|
Cash provided by operating activities
|
$16,854
|
$3,078
|
|||
|
Net cash used in investing activities
|
(76
|
)
|
(136
|
)
|
|
|
Net cash used in financing activities
|
(15,830
|
)
|
(3,743
|
)
|
|
|
Effect of exchange rate changes
|
42
|
(24
|
)
|
||
|
Increase (decrease) in cash and cash equivalents
|
$990
|
($825
|
)
|
||
|
Twenty-Six Week Periods Ended
|
|||||
|
June 27,
2020
|
June 29,
2019
|
||||
|
Net (loss) income
|
($6,937
|
)
|
$2,714
|
||
|
Adjustments to reconcile net income to cash
used in operating activities
|
5,977
|
1,494
|
|||
|
Changes in operating assets and liabilities:
|
|||||
|
Accounts receivable
|
12,227
|
(5,911
|
)
|
||
|
Prepaid expenses and other current assets
|
1,786
|
658
|
|||
|
Net of transit accounts receivable and payable
|
907
|
962
|
|||
|
Accounts payable and accrued expenses
|
2,739
|
(1,465
|
)
|
||
|
Accrued payroll and related costs
|
950
|
(1,217
|
)
|
||
|
Right of use assets and liabilities
|
3
|
259
|
|||
|
Income taxes payable
|
131
|
29
|
|||
|
Total adjustments
|
24,720
|
(5,191
|
)
|
||
|
Cash provided by (used in) operating activities
|
$17,783
|
($2,477
|
)
|
||
|
Net cash used in investing activities
|
(111
|
)
|
(238
|
)
|
|
|
Net cash (used in) provided by financing activities
|
(17,764
|
)
|
3,140
|
||
|
Effect of exchange rate changes
|
(123
|
)
|
(39
|
)
|
|
|
(Decrease) increase in cash and cash equivalents
|
($215
|
)
|
$386
|
||
|
Thirteen Week Period Ended June 27, 2020
|
||||||||
|
Engineering
|
Specialty
Health Care
|
Information
Technology
|
Consolidated
|
|||||
|
Revenue
|
$14,038
|
$10,684
|
$7,930
|
$32,652
|
||||
|
Cost of services
|
9,804
|
8,487
|
5,858
|
24,149
|
||||
|
Gross profit
|
$4,234
|
$2,197
|
$2,072
|
$8,503
|
||||
|
Gross profit margin
|
30.2
|
%
|
20.6
|
%
|
26.1
|
%
|
26.0
|
%
|
|
Thirteen Week Period Ended June 29, 2019
|
||||||||
|
Engineering
|
Specialty
Health Care
|
Information
Technology
|
Consolidated
|
|||||
|
Revenue
|
$18,583
|
$23,370
|
$8,752
|
$50,705
|
||||
|
Cost of services
|
13,324
|
18,057
|
6,521
|
37,902
|
||||
|
Gross profit
|
$5,259
|
$5,313
|
$2,231
|
$12,803
|
||||
|
Gross profit margin
|
28.3
|
%
|
22.7
|
%
|
25.5
|
%
|
25.3
|
%
|
|
Twenty-Six Week Period Ended June 27, 2020
|
||||||||
|
Engineering
|
Specialty
Health Care
|
Information
Technology
|
Consolidated
|
|||||
|
Revenue
|
$28,201
|
$32,881
|
$16,603
|
$77,685
|
||||
|
Cost of services
|
20,001
|
26,311
|
12,027
|
58,339
|
||||
|
Gross profit
|
$8,200
|
$6,570
|
$4,576
|
$19,346
|
||||
|
Gross profit margin
|
29.1
|
%
|
20.0
|
%
|
27.6
|
%
|
24.9
|
%
|
|
Twenty-Six Week Period Ended June 29, 2019
|
||||||||
|
Engineering
|
Specialty
Health Care
|
Information
Technology
|
Consolidated
|
|||||
|
Revenue
|
$37,638
|
$47,540
|
$17,122
|
$102,300
|
||||
|
Cost of services
|
27,682
|
36,593
|
12,705
|
76,980
|
||||
|
Gross profit
|
$9,956
|
$10,947
|
$4,417
|
$25,320
|
||||
|
Gross profit margin
|
26.5
|
%
|
23.0
|
%
|
25.8
|
%
|
24.8
|
%
|